With its expansion into St. Louis, Restore Brain continues its mission to broaden access to advanced psychiatric treatments and to redefine what is possible in modern mental health care. For more ...

PARK CITY, Utah, Nov. 6, 2023 /PRNewswire/ -- BlueWind Medical, Ltd., a pioneer in the development and commercialization of a patient centric implantable Tibial NeuroModulation (iTNM) solution for ...

Axonics (NASDAQ:AXNX) said it acquired a lead placement solution from Radian which complements the company's existing sacral neuromodulation (SNM) offering. The company acquired the assets of Radian ...

Neurolief announced today that the FDA granted approval for its Proliv Rx at-home neuromodulation therapy for treating ...

Gastroesophageal reflux disease (GERD) is a prevalent chronic condition characterized by recurrent reflux of stomach contents into the esophagus, leading to troublesome symptoms such as heartburn, ...

CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and ...

We expect free cash flow to improve through the year as the pandemic-driven delays in neuromodulation procedures ease. Cash flow growth should accelerate as we head into 2023. The firm does not pay a ...